The Times Of Bengal
For You Forever Yours
Powerhouse Duo Disrupts Functional Beverage Market with Science-Backed “Happiness”
Dr. Noor brings an elite medical pedigree: a Master’s in Public Health and triple specialty training in Internal Medicine, General…
Read More
Alcohólicos Anónimos recibe a tres nuevos custodios no alcohólicos en la Junta de Servicios Generales
NUEVA YORK, 22 de enero de 2026 /PRNewswire-HISPANIC PR WIRE/ — La Junta de Servicios Generales de Alcohólicos Anónimos (AA)…
Read More
MedStar Health Survey Finds Nearly Three-Quarters of Adults Are Concerned About Heart Health, But Many Aren’t Telling Their Doctor
COLUMBIA, Md., Feb. 2, 2026 /PRNewswire/ — A new national MedStar Health survey found 71% of adults are at least…
Read More
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTON, Mass., Feb. 2, 2026 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,…
Read More
FUGO Precision 3D to Debut Revolutionary Centrifugal 3D Printing Technology with Live Demonstrations at LMT LAB DAY Chicago 2026
GARDENA, Calif., Feb. 2, 2026 /PRNewswire/ — FUGO Precision 3D, developer of the world’s first all-in-one centrifugal 3D printing system,…
Read More
DaVita Inc. 4th Quarter 2025 Results
DENVER, Feb. 2, 2026 /PRNewswire/ — DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year…
Read More
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
KING OF PRUSSIA, Pa., Feb. 2, 2026 /PRNewswire/ — Universal Health Services, Inc. (NYSE: UHS) announced today that it will…
Read More
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Feb. 2, 2026 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the…
Read More
Polaris Completes Separation of Indian Motorcycle and Sale of Majority Stake to Carolwood LP
MINNEAPOLIS, Feb. 2, 2026 /PRNewswire/ — Polaris Inc. (NYSE: PII) (“Polaris” or “the Company”) today announced the completion of its…
Read More
CREATE Medicines Demonstrates Complete B Cell Depletion and Repeatable Dosing in Non-human Primates with In Vivo CAR-T Platform
Industry-leading non-human primate (NHP) data validates CREATE’s differentiated receptor design, targeted RNA-LNP platform, and ability to repeat dose Clinical entry…
Read More